Luyan Pharma Co.,Ltd. (SHE:002788)
China · Delayed Price · Currency is CNY 10.78
+0.34 (3.26%)
Sep 16, 2026, 3:04 PM CST
Luyan Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 648.67 | 616.96 | 576.85 | 606.3 | 594.19 | 415.43 |
Cash & Short-Term Investments | 648.67 | 616.96 | 576.85 | 606.3 | 594.19 | 415.43 |
Cash Growth | 26.24% | 6.95% | -4.86% | 2.04% | 43.03% | -30.40% |
Accounts Receivable | 6,214 | 6,392 | 5,951 | 5,673 | 5,849 | 5,101 |
Other Receivables | 116.44 | 103.42 | 108.33 | 94.59 | 87.49 | 117.17 |
Receivables | 6,330 | 6,495 | 6,059 | 5,768 | 5,937 | 5,218 |
Inventory | 2,931 | 3,035 | 2,865 | 2,574 | 2,549 | 2,275 |
Prepaid Expenses | 0.01 | 0.02 | 0.02 | 0.25 | 0.33 | 0.08 |
Other Current Assets | 348.48 | 310.48 | 369.1 | 370.33 | 668.17 | 414.12 |
Total Current Assets | 10,258 | 10,458 | 9,870 | 9,319 | 9,748 | 8,322 |
Property, Plant & Equipment | 2,087 | 2,099 | 1,928 | 1,653 | 1,425 | 1,037 |
Long-Term Investments | 59.81 | 63.84 | 53.41 | 48.85 | 34.21 | 31.3 |
Goodwill | 289.28 | 289.28 | 289.28 | 288.65 | 289.45 | 289.45 |
Other Intangible Assets | 363.52 | 356.38 | 361.09 | 355.16 | 176.93 | 167.81 |
Long-Term Deferred Tax Assets | 80.51 | 78.45 | 75.79 | 66.37 | 54.71 | 43.39 |
Long-Term Deferred Charges | 25.28 | 24.26 | 29.04 | 28.58 | 28.96 | 32.82 |
Other Long-Term Assets | 24.49 | 26.54 | 31.5 | 34.46 | 26.08 | 68.98 |
Total Assets | 13,188 | 13,396 | 12,639 | 11,794 | 11,784 | 9,993 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4,010 | 4,710 | 4,004 | 3,444 | 3,258 | 2,410 |
Accrued Expenses | 67.33 | 94.08 | 86.74 | 98.53 | 119.54 | 111.6 |
Short-Term Debt | 4,430 | 4,088 | 3,875 | 3,990 | 4,455 | 4,130 |
Current Portion of Long-Term Debt | 300.76 | 340.55 | 293.91 | 171.26 | 58.25 | 47.31 |
Current Portion of Leases | 48.01 | 52.26 | 46.67 | 43.54 | 37.98 | 41.69 |
Current Income Taxes Payable | 30.17 | 34.48 | 36.67 | 43.98 | 43.47 | 45.42 |
Current Unearned Revenue | 47.86 | 19.27 | 30.72 | 22.38 | 31.78 | 10.57 |
Other Current Liabilities | 356.4 | 243.19 | 232.47 | 211.84 | 296.53 | 217.69 |
Total Current Liabilities | 9,290 | 9,582 | 8,605 | 8,026 | 8,301 | 7,015 |
Long-Term Debt | 429.07 | 327.23 | 648.41 | 578.63 | 475.04 | 226.6 |
Long-Term Leases | 71.99 | 81.64 | 87.33 | 74.33 | 53.86 | 40.37 |
Long-Term Unearned Revenue | 40.98 | 38.24 | 38.83 | 39.76 | 41.2 | 41.85 |
Long-Term Deferred Tax Liabilities | 6.13 | 6.27 | 6.54 | 6.81 | 7.07 | 7.34 |
Other Long-Term Liabilities | 23 | 35.92 | 60.14 | 90.98 | 114.97 | 101.17 |
Total Liabilities | 9,862 | 10,072 | 9,447 | 8,817 | 8,993 | 7,433 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 |
Additional Paid-In Capital | 617.81 | 617.81 | 617.54 | 631.05 | 653.6 | 656.37 |
Retained Earnings | 2,304 | 2,297 | 2,152 | 1,923 | 1,676 | 1,447 |
Comprehensive Income & Other | 3.1 | 3.82 | 4.24 | 3.84 | 2.82 | -0.5 |
Total Common Equity | 3,313 | 3,307 | 3,162 | 2,946 | 2,721 | 2,492 |
Minority Interest | 13.52 | 17.09 | 29.67 | 30.68 | 69.84 | 68.47 |
Shareholders' Equity | 3,327 | 3,324 | 3,192 | 2,977 | 2,791 | 2,560 |
Total Liabilities & Equity | 13,188 | 13,396 | 12,639 | 11,794 | 11,784 | 9,993 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 5,280 | 4,890 | 4,951 | 4,858 | 5,080 | 4,486 |
Net Cash (Debt) | -4,631 | -4,273 | -4,374 | -4,252 | -4,486 | -4,071 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -11.87 | -10.95 | -11.26 | -10.99 | -11.57 | -10.51 |
Filing Date Shares Outstanding | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 |
Total Common Shares Outstanding | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 | 388.52 |
Working Capital | 967.85 | 875.26 | 1,265 | 1,292 | 1,447 | 1,307 |
Book Value Per Share | 8.53 | 8.51 | 8.14 | 7.58 | 7.00 | 6.41 |
Tangible Book Value | 2,660 | 2,661 | 2,512 | 2,302 | 2,254 | 2,034 |
Tangible Book Value Per Share | 6.85 | 6.85 | 6.47 | 5.93 | 5.80 | 5.24 |
Buildings | 2,012 | 1,800 | 1,443 | 1,001 | 899.38 | 858.76 |
Machinery | 310.21 | 303.7 | 278.43 | 259.22 | 214.51 | 196.8 |
Construction In Progress | 143.72 | 320.85 | 471.48 | 616.59 | 509.06 | 139.74 |